ProKidney (PROK) has had the highest return since July 1, 2025 by a small-cap US stock, returning 481%.
ProKidney (PROK) has had the highest return since July 1, 2025 by a small-cap US stock, returning 481%.
| ASSET | % RETURN |
|---|---|
| ProKidney (PROK) | 481.03% |
| Sequans Communications (SQNS) | 221.09% |
| Sharplink Gaming (SBET) | 190.57% |
| Opendoor Technologies (OPEN) | 94.39% |
| Newegg Commerce (NEGG) | 81.84% |
| Amprius Technologies (AMPX) | 77.91% |
| Prime Medicine, Inc Common Stock (PRME) | 76.54% |
| Northern Dynasty Minerals (NAK) | 61.19% |
| Cogent Biosciences (COGT) | 60.17% |
| Ramaco Resources (METC) | 53.64% |
| So-Young International (SY) | 52.2% |
| Sana Biotechnology (SANA) | 51.45% |
| Studio City International (MSC) | 50% |
| Solid Power (SLDP) | 47.91% |
| United States Antimony (UAMY) | 47.53% |
| Bit Digital (BTBT) | 47.53% |
| Zevra Therapeutics (ZVRA) | 46.84% |
| Tilray (TLRY) | 44.71% |
| WK Kellogg (KLG) | 44.47% |
| Ramaco Resources (METCB) | 44.2% |
| Red Cat (RCAT) | 43.04% |
| Canaan (CAN) | 42.53% |
| Brazil Potash (GRO) | 42.22% |
| Standard Lithium (SLI) | 40.82% |
| Neurogene (NGNE) | 38.52% |
Small-cap stocks are treated as having a market cap between $300M and $2B.